InvestSMART

Anagenics Limited (ASX: AN1) - Announcements

- Current share price for AN1 : $0.005

ASX company news and announcements for Anagenics Limited (AN1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anagenics Limited (AN1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anagenics Limited (AN1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anagenics Limited (AN1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5 Change of Director's Interest Notice - Greasley 16 Sep 2022 9:37AM $0.038 $0.005 fallen by 86.84%
$5 Appendix 4E and FY22 Financial Report 25 Aug 2022 9:08AM $0.032 $0.005 fallen by 84.38%
$5 Advangen Japan Divestment and Earn-Out Agreement 26 Jul 2022 8:45AM $0.030 $0.005 fallen by 83.33%
$5 Appendix 4C and Quarterly Activity Report 26 Jul 2022 8:35AM $0.030 $0.005 fallen by 83.33%
$5 Notification of cessation of securities - AN1 14 Jul 2022 5:01PM $0.033 $0.005 fallen by 84.85%
$5 Initial Director's Interest Notice - Greasley 8 Jul 2022 9:38AM $0.032 $0.005 fallen by 84.38%
$5 Appointment of Exec Director, Corporate and Trading Update 8 Jul 2022 9:34AM $0.032 $0.005 fallen by 84.38%
$5 Appendix 4C and Quarterly Activity Report 28 Apr 2022 8:52AM $0.043 $0.005 fallen by 88.37%
$5 New Leadership Driving Business Transformation 16 Mar 2022 9:52AM $0.048 $0.005 fallen by 89.58%
$5 Notification of cessation of securities - AN1 2 Mar 2022 5:11PM $0.047 $0.005 fallen by 89.36%
$5 Final Director's Interest Notice - Halasz 1 Mar 2022 9:37AM $0.049 $0.005 fallen by 89.80%
$5 Anagenics Appoints CEO 1 Mar 2022 9:27AM $0.049 $0.005 fallen by 89.80%
$5 Appendix 4D and Half Year Report 15 Feb 2022 4:56PM $0.054 $0.005 fallen by 90.74%
$5 Initial Director's Interest Notice - Beard 15 Feb 2022 2:27PM $0.050 $0.005 fallen by 90%
$5 Final Director's Interest Notice - Gordon 15 Feb 2022 2:25PM $0.050 $0.005 fallen by 90%
$5 Anagenics Board and Leadership Transition 15 Feb 2022 2:20PM $0.050 $0.005 fallen by 90%
$5 Change of Director's Interest Notice - Halasz 2 Feb 2022 5:29PM $0.049 $0.005 fallen by 89.80%
$5 Appendix 4C and Quarterly Activity Report 28 Jan 2022 9:21AM $0.053 $0.005 fallen by 90.57%
$5 Change in substantial holding from HNG 20 Jan 2022 10:57AM $0.054 $0.005 fallen by 90.74%
$5 Change of Director's Interest Notice - DE 7 Jan 2022 5:05PM $0.056 $0.005 fallen by 91.07%
$5 Cleansing Notice 7 Jan 2022 4:56PM $0.056 $0.005 fallen by 91.07%
$5 Application for quotation of securities - AN1 7 Jan 2022 4:44PM $0.056 $0.005 fallen by 91.07%
$5 Release of Shares from Voluntary Escrow 7 Jan 2022 9:19AM $0.056 $0.005 fallen by 91.07%
$5 Second Supply Agreement for Anagenics' FGF5 Inhibitors 24 Dec 2021 9:27AM $0.057 $0.005 fallen by 91.23%
$5 Change of Company Name 15 Dec 2021 12:18PM n/a $0.005 n/a

201 - 225 of 225 results

Page 9 of 9

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.